Delivery Order SPE2DB22D2211-SPE2DB24FMEB0
Award Date 11/16/23
Potential Completion Date 11/17/23
Potential Value $4.8K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of Ropivacaine 0.2% 400 mg/200 ml medication, valued at $6,539.27, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order placed against Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which supplies a comprehensive range of pharmaceutical products and medical supplies to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Ropivacaine 0.2% 400 mg/200 ml injections. The contract, valued at $9,396.54, is a firm fixed-price delivery order with an ultimate completion date of October 17, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The company holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,174.42 firm fixed-price delivery order is for the supply of Ropivacaine 0.2% 400 mg/200 ml medication, with a completion date of January 29, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4554735557 - Ropivacaine 0.2% 400 mg/200 ml 200 ml. The firm-fixed-price delivery order, valued at $10,088.92, has a completion date of September 13, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is registered in the System for Award Management (SAM.gov) and operates as a for-profit...
- This federal contract award, with ID SPE2DX15D3404|SPE2DX24F0YJF, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order valued at $3,773.42 for the supply of 400 mg/200 mL of the pharmaceutical product Ropivacaine 0.2%. The contract has no set-aside designation, indicating open competition. It is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc....
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,639.35, is for the delivery of Ropivacaine 0.2% 400 mg/200 ml medication. The contract is a Firm Fixed Price Delivery Order with a completion date of February 24, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 400 mg/200 mL bottles of the pharmaceutical drug Ropivacaine 0.2%. The contract is a Delivery Order valued at $2,734.75 with a firm fixed price, and has an ultimate completion date of March 12, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) Medical Supply Chain for the delivery of Ropivacaine 0.2% 400 mg/200 ml injectables. The contract, identified as SPE2DX15D1053|SPE2DX24F6CZS, is a Firm Fixed Price Delivery Order with a ceiling value of $5,396.69 and a period of performance through November 27, 2023. The contract is not designated as a set-aside. Amerisourcebergen, a major pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,162.25 firm fixed-price delivery order is for 4563554227 - Ropivacaine 0.2% 400 mg/200 ml, a pharmaceutical product used for pain management. The contract has an ultimate completion date of February 6, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, identified as SPE2DB22D3016|SPE2DB24FAEC0, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $2,594.70, is for the delivery of Ropivacaine 0.2% 400 mg/200 mL medication. This is a Firm Fixed Price delivery order contract with an ultimate completion date of November 27, 2023. The contract does not have a set-aside designation, indicating it was awarded through full and open...